Search Results

You are looking at 21 - 30 of 74 items for :

  • "chemotherapy administration" x
  • All content x
Clear All
Full access

Jeffrey Crawford, James Armitage, Lodovico Balducci, Charles Bennett, Douglas W. Blayney, Spero R. Cataland, David C. Dale, George D. Demetri, Harry P. Erba, James Foran, Alison G. Freifeld, Marti Goemann, Mark L. Heaney, Sally Htoy, Susan Hudock, Dwight D. Kloth, David J. Kuter, Gary H. Lyman, Laura Boehnke Michaud, Sarah C. Miyata, Martin S. Tallman, Saroj Vadhan-Raj, Peter Westervelt, and Michael K. Wong

(glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin’s lymphoma: factors influencing chemotherapy administration. Groupe d’Etude des Lymphomes de l’Adulte . Leuk Lymphoma 1997 ; 25 : 289 – 300 . 5 Timmer

Full access

Julia C. Shih and Anthony J. Olszanski

Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology . Oncol Nurs Forum 2017;44:31–43. 11. Bennett AV , Jensen RE , Basch E . Electronic patient

Full access

Marina Stasenko, R. Kevin Reynolds, Carolyn Johnston, Melissa Brackman, Karen McLean, and Shitanshu Uppal

-dense chemotherapy were requested. Specifically, parameters sought were ANC and platelet count on day 1, 8, and 15 of each cycle of chemotherapy administration. The email included the following fill-in lines to allow for quick response from the participants: “ANC on

Full access

Craig A. Bunnell, Katya Losk, Sarah Kadish, Nancy Lin, Judith Hirshfield-Bartek, Linda Cutone, Kristen Camuso, Mehra Golshan, and Saul Weingart

, chemotherapy administration, and radiation appointments from 4 separate health information and scheduling systems ( Table 3 ). Table 2 Patient Criteria for Data Extraction and Analysis A timeline was generated for each patient that captured

Full access

Pilar de la Morena Barrio, María Ángeles Vicente Conesa, Enrique González-Billalabeitia, Edgar Urrego, Elisa García-Garre, Elena García-Martínez, Marta Zafra Poves, Vicente Vicente, and Francisco Ayala de la Peña

chemotherapy administration, or stricter glycemic control during chemotherapy administration. Other approaches to ameliorate the development of peripheral neuropathy have been proposed, such as changes in time of infusion or concurrent administration of

Full access

Jamie M. Jacobs, Molly E. Ream, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Joanne Buzaglo, Inga T. Lennes, Steven A. Safren, William F. Pirl, Jennifer S. Temel, and Joseph A. Greer

chemotherapy and beyond . Br J Cancer 2002 ; 87 : 933 – 937 . 10.1038/sj.bjc.6600591 12434279 2. Neuss MN , Polovich M , McNiff K , . 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety

Full access

Jagar Jasem, Christine M. Fisher, Arya Amini, Elena Shagisultanova, Rachel Rabinovitch, Virginia F. Borges, Anthony Elias, and Peter Kabos

, tumor size, and number of nodes involved. In a similar but smaller study of 111 patients with ER-positive EBC, the rate of chemotherapy administration Figure 2. Patterns of chemotherapy for patients with intermediate recurrence scores (RS) based

Full access

Yanli Li, Leila Family, Su-Jau Yang, Zandra Klippel, John H. Page, and Chun Chao

of the chemotherapy course was defined as the date of initial chemotherapy administration, and the end date was defined as the last date of administration of selected chemotherapy regimens with a subsequent gap of ≥60 days. Information on the

Full access

James M. Hoffman, Donald K. Baker, Scott C. Howard, Joseph H. Laver, and Jerry L. Shenep

for chemotherapy was safe enough. Approval of Chemotherapy Administration by an Attending Oncologist One critically important improvisation in the implementation of CPOE for chemotherapy was to embed an electronic order detail in each

Full access

John M. Salsman, Steven M. Grunberg, Jennifer L. Beaumont, Miriam Rogers, Diane Paul, Marla L. Clayman, and David Cella

chemotherapy administration. 12 This underscores the problem that delayed CINV usually occurs after hospital or clinic discharge, when patients do not have immediate contact with their providers, thus requiring patient initiative to make the provider aware of